dacarbazine has been researched along with Anasarca in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Apaijai, N; Chattipakorn, N; Chattipakorn, SC; Limpastan, K; Nanegrungsunk, D; Sripetchwandee, J; Vaniyapong, T; Watcharasaksilp, W; Yarana, C | 1 |
| Akioka, T; Hanafusa, T; Hiraoka, N; Hirata, Y; Iwaki, K; Kobayashi, K; Nakayama-Ichiyama, S; Oka, S; Takayama, A; Takubo, T; Tsuji, M; Yokote, T | 1 |
| Casey, DJ; Kim, AY; Olszewski, AJ | 1 |
| Kefford, R; Lim, I; Manolios, N | 1 |
| Baumgart, U; Bogdahn, U; Hau, P; Hirschmann, B; Kunz-Schughart, L; Muhleisen, H; Reichle, A; Ruemmele, P; Steinbrecher, A; Weimann, E | 1 |
| Ariyan, S; Poo, WJ | 1 |
| Aliaga, A; Camps, C; Febrer, I; Godes, M; Pujol, C; Serrano, G | 1 |
1 trial(s) available for dacarbazine and Anasarca
| Article | Year |
|---|---|
Low-dose chemotherapy in combination with COX-2 inhibitors and PPAR-gamma agonists in recurrent high-grade gliomas - a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Brain Neoplasms; Capecitabine; Cyclooxygenase 2 Inhibitors; Dacarbazine; Deoxycytidine; Drug Administration Schedule; Edema; Efferent Pathways; Erythema; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Glioblastoma; Glioma; Humans; Immunohistochemistry; Lactones; Male; Middle Aged; Neoplasm Recurrence, Local; Neovascularization, Pathologic; Pioglitazone; PPAR gamma; Predictive Value of Tests; Quality of Life; Sulfones; Temozolomide; Thiazolidinediones; Treatment Outcome | 2007 |
6 other study(ies) available for dacarbazine and Anasarca
| Article | Year |
|---|---|
Bevacizumab is superior to Temozolomide in causing mitochondrial dysfunction in human brain tumors.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents, Alkylating; Bevacizumab; Brain Neoplasms; Calcium Chloride; Dacarbazine; Dose-Response Relationship, Drug; Edema; Female; Humans; Male; Membrane Potential, Mitochondrial; Microscopy, Electron, Transmission; Mitochondria; Reactive Oxygen Species; Retrospective Studies; Temozolomide; Tumor Cells, Cultured | 2016 |
Multiple-cytokine-producing, mixed-cellularity, classical Hodgkin lymphoma with B symptoms and minimal-change nephrotic syndrome.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; C-Reactive Protein; Dacarbazine; Doxorubicin; Edema; Fatigue; Fever; Hodgkin Disease; Humans; Immunosuppressive Agents; Interleukin-6; Male; Nephrosis, Lipoid; Paraneoplastic Syndromes; Recurrence; Reed-Sternberg Cells; Sweating; Tumor Necrosis Factor-alpha; Vinblastine | 2010 |
Progressive pericardial effusion during chemotherapy for advanced Hodgkin lymphoma.
Topics: Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiac Tamponade; Dacarbazine; Diagnosis, Differential; Diuretics; Doxorubicin; Edema; Electrocardiography; Furosemide; Hodgkin Disease; Humans; Male; Middle Aged; Multimodal Imaging; Myocardial Infarction; Neoplasm Staging; Pericardial Effusion; Pericarditis; Positron-Emission Tomography; Serositis; Tomography, X-Ray Computed; Ultrasonography; Vinblastine | 2012 |
Chemotherapeutic induced fascial oedema.
Topics: Antineoplastic Agents, Alkylating; Dacarbazine; Drug Eruptions; Edema; Fascia; Female; Humans; Melanoma; Middle Aged; Thigh | 2005 |
Safety and efficacy of isolated perfusion of extremities for recurrent tumor in elderly patients.
Topics: Adult; Age Factors; Aged; Antineoplastic Agents; Dacarbazine; Edema; Extremities; Female; Humans; Male; Melanoma; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Outcome Assessment, Health Care; Perfusion; Recurrence; Skin Neoplasms | 1998 |
Dacarbazine-induced photosensitivity.
Topics: Dacarbazine; Edema; Erythema; Facial Dermatoses; Female; Humans; Leiomyosarcoma; Middle Aged; Photosensitivity Disorders; Uterine Neoplasms | 1989 |